Anixa Biosciences Inc. (NASDAQ: ANIX) stock closed at 4.23 per share at the end of the most recent trading day (a 1.93% change compared to the prior day closing price) with a volume of 61.60K shares and market capitalization of 126.69M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 4 people. Anixa Biosciences Inc. CEO is Amit Kumar.

The one-year performance of Anixa Biosciences Inc. stock is 90.5%, while year-to-date (YTD) performance is 37.79%. ANIX stock has a five-year performance of %. Its 52-week range is between 1.7 and 8.09, which gives ANIX stock a 52-week price range ratio of 39.59%

Anixa Biosciences Inc. currently has a PE ratio of -10.40, a price-to-book (PB) ratio of 9.87, a price-to-sale (PS) ratio of 242.52, a price to cashflow ratio of 18.90, a PEG ratio of 2.32, a ROA of -90.26%, a ROC of -100.90% and a ROE of -98.53%. The company’s profit margin is -%, its EBITDA margin is -1 854.50%, and its revenue ttm is $512.50 Thousand , which makes it $0.02 revenue per share.

Of the last four earnings reports from Anixa Biosciences Inc., there were 2 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.11 for the next earnings report. Anixa Biosciences Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Anixa Biosciences Inc. is Strong Buy (1), with a target price of $9.5, which is +124.59% compared to the current price. The earnings rating for Anixa Biosciences Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Anixa Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Anixa Biosciences Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.65, ATR14 : 0.30, CCI20 : 48.73, Chaikin Money Flow : -0.02, MACD : -0.01, Money Flow Index : 63.07, ROC : 6.28, RSI : 51.98, STOCH (14,3) : 44.09, STOCH RSI : 0.43, UO : 44.99, Williams %R : -55.91), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Anixa Biosciences Inc. in the last 12-months were: Amit Kumar (Buy at a value of $120 680), Arnold Baskies (Buy at a value of $87 100), Emily Gottschalk (Buy at a value of $121 028), Lewis H. Titterton (Buy at a value of $515 380)